Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2025 Earnings Call Transcript November 3, 2025
Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-3.82132 EPS, expectations were $-3.3.
Operator: Good morning. My name is Ludy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being...
